Поисковый запрос: (<.>S=ОФТАЛЬМОПАТИЯ ГРЕЙВСА<.>) |
Общее количество найденных документов : 81
Показаны документы с 1 по 20
|
|
1.
| Antibodies stimulating eye muscle cells in Graves' ophthalmopathy // Ann. endocrinol., 1991. Vol. 52, N 1.-С.63
|
2.
| Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry // Radiother. and Oncol., 1999. Vol. 53, N 3.-С.205-208
|
3.
| Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry // Radiother. and Oncol., 1999. Vol. 53, N 3.-С.205-208
|
4.
| Association of PARP-1, NF-'каппа'B, NF-'каппа'BIA and IL-6, IL-1'бета' and TNF-'альфа' with Graves Disease and Graves Ophthalmopathy // Gene, 2014. Vol. 547, N 2.-С.226-232
|
5.
| Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy // Clin. Endocrinol., 2000. Vol. 52, N 3.-С.267-271
|
6.
| Autonomous thyroid nodule associated with Grave's ophthalmopathy // Acta endocrinol., 2006. Vol. 2, N 4.-С.505
|
7.
| Bartalena L. Prevention of Graves' ophthalmopathy // Best Pract. and Res. Clin. Endocrinol. and Metab., 2012. Vol. 26, N 3.-С.371-379
|
8.
| Bartalena L. Prevention of Graves' ophthalmopathy // Best Pract. and Res. Clin. Endocrinol. and Metab., 2012. Vol. 26, N 3.-С.371-379
|
9.
| Bartalena Orbital radiotherapy for Graves' ophthalmopathy // J. Clin. Endocrinol. and Metab., 2004. Vol. 89, N 1.-С.13-14
|
10.
| Ching C.-L. Ethnic differences in the clinical presentation of Graves' ophthalmopathy // Best Pract. and Res. Clin. Endocrinol. and Metab., 2012. Vol. 26, N 3.-С.249-258
|
11.
| Ching C.-L. Ethnic differences in the clinical presentation of Graves' ophthalmopathy // Best Pract. and Res. Clin. Endocrinol. and Metab., 2012. Vol. 26, N 3.-С.249-258
|
12.
| Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies // Clin. Endocrinol., 2004. Vol. 61, N 5.-С.612-618
|
13.
| Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathy // Clin. Endocrinol., 2004. Vol. 60, N 6.-С.726-733
|
14.
| Disease-specific assessment of quality of life after decompression surgery for Graves' ophthalmopathy // Eur. J. Ophthalmol., 2004. Vol. 14, N 3.-С.193-199
|
15.
| Eckstein A. Surgical treatment of Graves' ophthalmopathy // Best Pract. and Res. Clin. Endocrinol. and Metab., 2012. Vol. 26, N 3.-С.339-358
|
16.
| Eckstein A. Surgical treatment of Graves' ophthalmopathy // Best Pract. and Res. Clin. Endocrinol. and Metab., 2012. Vol. 26, N 3.-С.339-358
|
17.
| Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy // Clin. Endocrinol., 2011. Vol. 74, N 1.-С.118-124
|
18.
| Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy // Clin. Endocrinol., 2011. Vol. 74, N 1.-С.118-124
|
19.
| Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of Graves ophthalmophathy // Thyroid, 2003. Vol. 13, N 7.-С.12-13
|
20.
| Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy // J. Clin. Endocrinol. and Metab., 2004. Vol. 89, N 2.-С.930-935
|
&uf('+1W2226#',v2226), ?>
|
|